WO2009004282A2 - Pansement médical - Google Patents
Pansement médical Download PDFInfo
- Publication number
- WO2009004282A2 WO2009004282A2 PCT/GB2008/002011 GB2008002011W WO2009004282A2 WO 2009004282 A2 WO2009004282 A2 WO 2009004282A2 GB 2008002011 W GB2008002011 W GB 2008002011W WO 2009004282 A2 WO2009004282 A2 WO 2009004282A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- film
- dressing
- medical dressing
- skin
- backing
- Prior art date
Links
- 206010014989 Epidermolysis bullosa Diseases 0.000 claims abstract description 18
- 230000001464 adherent effect Effects 0.000 claims abstract description 7
- 230000002265 prevention Effects 0.000 claims abstract description 6
- 230000037380 skin damage Effects 0.000 claims abstract description 3
- 230000035699 permeability Effects 0.000 claims description 14
- 239000004744 fabric Substances 0.000 claims description 13
- 239000000853 adhesive Substances 0.000 claims description 10
- 230000001070 adhesive effect Effects 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 230000036571 hydration Effects 0.000 claims description 4
- 238000006703 hydration reaction Methods 0.000 claims description 4
- 229920003023 plastic Polymers 0.000 claims description 4
- 239000004033 plastic Substances 0.000 claims description 4
- 229920002635 polyurethane Polymers 0.000 claims description 4
- 239000004814 polyurethane Substances 0.000 claims description 4
- 239000000314 lubricant Substances 0.000 claims description 3
- 239000004599 antimicrobial Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 230000000284 resting effect Effects 0.000 claims 2
- 230000000845 anti-microbial effect Effects 0.000 claims 1
- 239000012867 bioactive agent Substances 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 208000025865 Ulcer Diseases 0.000 abstract description 4
- 231100000397 ulcer Toxicity 0.000 abstract description 4
- 239000003246 corticosteroid Substances 0.000 abstract description 2
- 229960001334 corticosteroids Drugs 0.000 abstract description 2
- 208000026350 Inborn Genetic disease Diseases 0.000 abstract 1
- 208000000453 Skin Neoplasms Diseases 0.000 abstract 1
- 208000016361 genetic disease Diseases 0.000 abstract 1
- 201000000849 skin cancer Diseases 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 39
- 210000003491 skin Anatomy 0.000 description 30
- 208000027418 Wounds and injury Diseases 0.000 description 21
- 206010052428 Wound Diseases 0.000 description 19
- 208000014674 injury Diseases 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 8
- 230000008733 trauma Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 230000002500 effect on skin Effects 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 229920002334 Spandex Polymers 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 229920006264 polyurethane film Polymers 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 208000005230 Leg Ulcer Diseases 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 210000002469 basement membrane Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002803 maceration Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- -1 polypropylene Polymers 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 201000002282 venous insufficiency Diseases 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 206010062542 Arterial insufficiency Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006803 Burns third degree Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 206010056340 Diabetic ulcer Diseases 0.000 description 1
- 208000035752 Live birth Diseases 0.000 description 1
- 241000408521 Lucida Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 208000037340 Rare genetic disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000001266 bandaging Methods 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229920000554 ionomer Polymers 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 229920002620 polyvinyl fluoride Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0273—Adhesive bandages for winding around limb, trunk or head, e.g. cohesive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/06—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings
- A61F13/064—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings for feet
- A61F13/069—Decubitus ulcer bandages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00157—Wound bandages for burns or skin transplants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00157—Wound bandages for burns or skin transplants
- A61F2013/00161—Wound bandages for burns or skin transplants with wax, e.g. petroleum or bees
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00217—Wound bandages not adhering to the wound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00217—Wound bandages not adhering to the wound
- A61F2013/00229—Wound bandages not adhering to the wound with alginate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00246—Wound bandages in a special way pervious to air or vapours
- A61F2013/00259—Wound bandages in a special way pervious to air or vapours thin film
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00246—Wound bandages in a special way pervious to air or vapours
- A61F2013/00263—Wound bandages in a special way pervious to air or vapours vapour permeability >500 g/m2/24h
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00314—Wound bandages with surface treatments
- A61F2013/00331—Wound bandages with surface treatments lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00387—Plasters use skin protection
- A61F2013/00395—Plasters use skin protection from skin abrasion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00519—Plasters use for treating burn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/0054—Plasters use for deep wounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00544—Plasters form or structure
- A61F2013/00604—Multilayer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00855—Plasters pervious to air or vapours
- A61F2013/00868—Plasters pervious to air or vapours thin film
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/0091—Plasters containing means with disinfecting or anaesthetics means, e.g. anti-mycrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/00927—Plasters containing means with biological activity, e.g. enzymes for debriding wounds or others, collagen or growth factors
Definitions
- the invention relates to a medical dressing, particularly, but not exclusively for the clinical management of fragile or easily damaged areas of the epidermis or dermal tissue resulting from conditions such as trauma, burns, epidermolysis bullosa, or cancer.
- the dressing will find application also in both the emergency and long term management of serious or extensive burns, and that it will be of value in the management of battlefield injuries. It will also be of value in the treatment of exuding wounds such as ulcers, for example, caused by diabetes, arterial or venous insufficiency.
- EB Epidermolysis bullosa
- EBS EB Simplex
- JEB Junctional EB
- Dystrophic EB occurs under the basement membrane. An estimated 50 in 1 million live births are diagnosed with EB. Of these cases, approximately 92% are EBS, 5% are DEB, 1% are JEB, and 2% are unclassified. The disorder occurs in every racial and ethnic group throughout the world and affects both genders.
- any action that creates friction between the skin layers will create blisters and painful sores, sometimes compared to third-degree burns which can involve very large areas of the body and take extended times to heal.
- Other people who have friable or easily damaged skin not associated with EB include the elderly or individuals who are receiving topical or systemic corticosteroids for a pre-existing skin or medical condition and patients with serious burns particularly during transportation to hospital or specialist treatment centres.
- low-adherent dressings include plain gauze impregnated in white soft paraffin or some similar ointment basis, or fabric coated with silicone in various forms to provide a non adherent interface layer between the skin or wound and some form of secondary dressing.
- these dressings are presented in individual pieces commonly measuring 10 cm x 10cm or multiples thereof which must be applied singly forming a patchwork of dressings over the affected area.
- These dressings in turn must be held in place with a secondary retention system such as a lightweight bandage or surgical stockinette. Surgical tape cannot be used as this will cause trauma to the surrounding skin upon removal and lead to the formation of fresh blisters in EB suffers.
- plastic food wrap is used to provide a low adherent conformable covering but this brings problems of its own, as such materials are of very limited permeability to moisture vapour and permit the accumulation of sweat and skin secretions under the film. The accumulation of fluid in this way causes maceration and increases the possibility of infection. Plastic film food wrap is also very difficult to handle and apply as it tends to collapse upon itself once removed from the roll.
- Embodiments of the invention address the problems mentioned above by providing a medical dressing suitable for the prevention and management of skin damage in patients who are at particular risk of injuries cause by EB as well as more general management and prevention of damaged or vulnerable skin, wounds etc and underlying tissue.
- One feature of these embodiments is the provision of a moisture vapour permeable film, a so called semipermeable film, in use, arranged to be in direct but non adherent contact with the skin.
- Semipermeable films are also used to form the backing layer of absorbent dressings.
- the function of the absorbent layer is to absorb exudate from wounds such as leg ulcers and pressure sores.
- the inner layer of the dressing is made from a sheet of foam typically 2-5 mm thick.
- the film can be used as a carrier for an absorbent adhesive mass containing carboxymethylcellulose (CMC), starch or other types of gel-forming agents resulting in products commonly described as hydrogel sheets or hydrocolloid dressings. in all of these composite products the film is not placed in direct contact with the skin but is used to form a liquid and/or bacterial barrier on the outer surface of the dressing.
- CMC carboxymethylcellulose
- starch or other types of gel-forming agents resulting in products commonly described as hydrogel sheets or hydrocolloid dressings.
- the film is not placed in direct contact with the skin but is used to form a liquid and/or bacterial barrier on the outer surface of the dressing.
- skin dressing comprising a semipermeable film arranged to be in direct contact with the skin and a backing layer, the backing layer supporting the film in use in said contact.
- the dressing is in the form of a roll. In another embodiment the dressing is in the form of discrete lengths.
- a suitable film can be made from a suitable material such as: polyurethane; polyvinylchloride; polyvinylidene chloride; polyvinyl alcohol; polysulfone; polystyrene; polypropylene; polyethylene; polyamide; ethylene- vinylacetate copolymer; polyester; polycarbonate; ionomer; polyvinylfluoride and
- FEP fluoropolymer or combinations thereof The preferred moisture vapour permeable film is polyurethane. Since the film is continuous, it will have no perforations or pores which extend through the thickness of the film.
- the film may be semipermeable such that it is permeable to varying degrees of vapour, such as water vapour, but substantially impermeable to liquids, such as water, and microorganisms such as bacteria.
- vapour such as water vapour
- liquids such as water, and microorganisms such as bacteria.
- the film thus forms an effective barrier to contamination whilst allowing the wound and surrounding skin to dissipate sweat or wound fluid as moisture vapour.
- the film may include the ability to change its permeability according to the state of its hydration.
- the permeability decreases as hydration decreases
- there is a practical advantage to the management of exuding wounds because the permeability of the film will reduce as the wound heals and exudate production diminishes, maintaining a moist but not macerated environment which has been shown to facilitate rapid wound healing.
- polyurethane film is used, this offers many practical advantages in the treatment or prevention of traumatic injuries to easily damaged skin.
- the film is highly conformable, has a low coefficient of friction and can be produced in various thickness and permeabilities, in an almost unlimited range of sizes.
- the backing layer may be in the form of a lightweight secondary layer bonded to the outer surface of the film.
- this layer is a layer of gauze, a thin web of nonwoven fabric, a thin layer of foam, with or without apertures to facilitate passage of moisture vapour, or a piece of woven or knitted textile fabric forming. an open mesh.
- the backing fabric is impregnated with a lubricant to further reduce friction between the outer surface of the completed dressing and clothing or bed linen.
- backing layer is elasticated and is bonded to the film whilst the backing layer is under slight extension. This has the effect of creating a dressing having a wrinkled film when the backing layer is released from tension. The dressing can then be stretched in use up to an extension where the film is no longer wrinkled.
- the dressing resembles a lightweight retention bandage that will conform closely to the contours of the body without adhering to it. This intimate contact is important. If the dressing is not held in contact with the skin, fluid may accumulate beneath it which may lead to maceration.
- the invention could be used as a dressing for exuding wounds such as arterial or diabetic ulcers on the lower limb.
- the dressing is in the form of a bandage for applying compression in the treatment of leg ulcers caused by venous insufficiency.
- the film is applied in its stretched state under the degree of tension consistent with its clinical application.
- the dressing in the form of said bandage is stretched to the point at which all the wrinkles or slack within the film are removed and then it is applied, for example to a limb.
- the film would not only act as an effective primary dressing layer, but it would also limit the extension of the backing layer and ensure that the bandage was applied with the appropriate tension.
- the resultant dressing would be many times thinner than conventional ulcer dressings systems with obvious practical advantages to the patient who would have less difficulty fitting apparel such as socks, stockings or shoes over the dressing.
- the film could be coated or otherwise medicated with antimicrobial agents such as silver, iodine or complexes thereof or any other suitable bioactive molecule designed to facilitate or promote any stage in the healing process.
- the film could be coated with lubricant to reduce frictional forces between it and the skin.
- the dressing can be applied spirally in a continuous length using a conventional bandaging technique to dress digits, limbs or the torso.
- the dressing being lightweight, is relatively comfortable and conformable and will not greatly impede movement.
- the backing layer also serves a second important function in that it forms a spacer between overlapping layers of the film, thus allowing vapour to escape and maintaining the desired vapour transmission rate even though the dressing overlaps. If a roll of film without such a backing layer were to be applied in the form of a spiral with a 50% overlap like a conventional bandage, successive layers would come into intimate contact with each other thus effectively doubling the thickness of the dressing and approximately halving the moisture vapour permeability of the combination.
- Figure 1 shows a first embodiment of the invention in the form of a roll of bandage-like dressing
- Figure 2 shows an enlarged view if a section along the line M-Il of the dressing shown in Figure 1 ;
- Figure 3 shows the dressing of Figures 1 and 2 in use.
- the term skin refers the epidermis or dermal tissue area of a person or animal, including the outer exposed surface of tissue, for example a wound, where skin should be.
- the dressing comprises a stretchable fabric outer layer 14 and an inner layer 16 of hydrophilic polyurethane plastics film.
- the fabric outer layer comprises a stretchable bandage of knitted fabric having a generally open weave of viscose fibres together with elastically extensible material, in this case elastane.
- the elastane extends generally in the longitudinal direction X so that the dressing is stretchable in that direction.
- the polyurethane film 16 is extruded and is generally not stretchable.
- the film 16 is approximately 100 ⁇ m in thickness and has a permeability to water vapour of about 1g/cm 2 /24 hours at body temperature.
- the film 16 is bonded to the outer layer 14 by means of a suitable adhesive, such as a surgical acrylate or by other bonding means such as heat when the outer layer is in a stretched condition.
- a suitable adhesive such as a surgical acrylate or by other bonding means such as heat when the outer layer is in a stretched condition.
- the tension in the outer layer is released. This release causes the outer layer 14 and the film 16 to contract, so the film becomes wrinkled or puckered as shown in Figure 2.
- the dressing is stored in that condition and when used can be stretched.
- the dressing can be stretched by an amount governed by the film. When the film becomes taught, further extension of the dressing is inhibited. This feature prevents the dressing being applied with too much inherent tension.
- FIG. 3 shows the dressing 10 applied to the dermal tissue 30 of a patient.
- the dressing is stretched so that the film 16 is smoothly in direct contact with the tissue 30, allowing vapour 32 to escape in a controlled manner, keeping the tissue 30 at a suitable level of hydration.
- the dressing is intended to be spirally wound.
- the outer layer allows vapour to escape between overlapping layers of the dressing 10 and so maintaining the permeability of a single thickness of film.
- the inner layer 16 of the dressing is intended to contact directly the skin, although it is possible that an intervening layer, possibly only at the edges of the dressing, may be applied to the film 16 so that the film only contacts the skin in predefined areas, for example over an ulcer.
- the device is intended primarily for direct application to the skin, it could be usefully employed as a secondary dressing to be used in conjunction with a gel forming primary dressing made from alginate or CMC.
- Polyurethane film is described but any semipermeable continuous film could be employed.
- Such films may include therapeutic additives, such as medicines, biocides, antibiotics or other additives for assisting in healing or to increase the preventive ability of the dressing. It is possible to provide dressings having a range of permeabilities, but dressings having films which vary their permeability as mentioned above. A film permeability in the range of 0.5 to 5 g/cm 2 /24hours and a film thickness of 50 to 500 ⁇ m is preferred.
- the outer layer 14 is described above as a stretchable viscose fabric.
- Other permeable layers may be used as an alternative or in addition to the layer
- Alternatives or addition layers include woven fabrics such as a cotton weave, non woven fabrics such as a polyester felt, sheet materials such as perforated plastics or metals which could deform plastically, synthetic foams, or a combination of such materials.
- Elastic properties in the outer layer 14 are preferred but are not essential. If elastic properties are employed, these may be imparted by the use of yarns made from rubber, elastane or any other suitable material.
- the dressing can be produced in any suitable size or shape, including cupped shapes formed to at least partially surround vulnerable areas of the body, such as elbows, buttocks or heels.
- the dressings described above have the property that they are non adherent and readily removable from the skin or a wound, even if the wound is active. In other words they can be pulled away from the area where they have made contact, without significant trauma , or without significantly disturbing freshly healed, fragile, friable or delicate skin or wound tissues.
- the adhesive holding the film to the backing fabric may be applied in a continuous layer or in a discontinuous manner in the form of tramlines or spots or patches which would have the effect of increasing the total permeability of the device as certain adhesives can restrict the passage of moisture vapour through the film.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Abstract
L'invention concerne un pansement médical (10) pour la prévention ou le traitement des plaies cutanées et des ulcères, en particulier, chez les patients qui y sont prédisposés en raison de troubles médicaux ou génétiques tels que l'épidermolyse bulleuse, le cancer de la peau ou une peau fragile résultant de l'utilisation de corticostéroïdes. Le pansement est constitué d'un film non adhésif (16) stabilisé par un support (14). En utilisation, le film (16) peut être en contact direct avec la zone affectée chez le patient, le support maintenant le film en place.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0712714A GB0712714D0 (en) | 2007-07-01 | 2007-07-01 | A new dressing for the management of epidermolysis bullosa and other conditions involving fragile, easily damaged skin |
GB0712714.5 | 2007-07-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009004282A2 true WO2009004282A2 (fr) | 2009-01-08 |
WO2009004282A3 WO2009004282A3 (fr) | 2009-12-23 |
Family
ID=38420996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2008/002011 WO2009004282A2 (fr) | 2007-07-01 | 2008-06-12 | Pansement médical |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0712714D0 (fr) |
WO (1) | WO2009004282A2 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2415929A1 (fr) * | 2010-08-03 | 2012-02-08 | Zodiac Automotive Division | Matériau composite hautement déformable pour dispositifs médicaux |
WO2014011636A1 (fr) | 2012-07-10 | 2014-01-16 | Bio Med Sciences, Inc. | Nouvelle contre-mesure médicale destinée à des premiers intervenants, en cas de brûlures thermiques et/ou radiologiques affectant un très grand nombre de blûlés |
WO2021032361A1 (fr) * | 2019-08-19 | 2021-02-25 | Sigvaris Ag | Vêtement de compression médical doté d'une section d'articulation spéciale pour une plage de mouvement accrue |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3618754A (en) * | 1969-02-11 | 1971-11-09 | Kendall & Co | Conformable elastic adhesive tape |
US5188124A (en) * | 1989-07-19 | 1993-02-23 | Johnson & Johnson Consumer Products, Inc. | Low friction film dressing |
US5445604A (en) * | 1980-05-22 | 1995-08-29 | Smith & Nephew Associated Companies, Ltd. | Wound dressing with conformable elastomeric wound contact layer |
WO2005065604A1 (fr) * | 2004-01-07 | 2005-07-21 | Biopol Co., Ltd. | Pansement |
-
2007
- 2007-07-01 GB GB0712714A patent/GB0712714D0/en not_active Ceased
-
2008
- 2008-06-12 WO PCT/GB2008/002011 patent/WO2009004282A2/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3618754A (en) * | 1969-02-11 | 1971-11-09 | Kendall & Co | Conformable elastic adhesive tape |
US5445604A (en) * | 1980-05-22 | 1995-08-29 | Smith & Nephew Associated Companies, Ltd. | Wound dressing with conformable elastomeric wound contact layer |
US5188124A (en) * | 1989-07-19 | 1993-02-23 | Johnson & Johnson Consumer Products, Inc. | Low friction film dressing |
WO2005065604A1 (fr) * | 2004-01-07 | 2005-07-21 | Biopol Co., Ltd. | Pansement |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2415929A1 (fr) * | 2010-08-03 | 2012-02-08 | Zodiac Automotive Division | Matériau composite hautement déformable pour dispositifs médicaux |
FR2963626A1 (fr) * | 2010-08-03 | 2012-02-10 | Zodiac Automotive Division | Materiau composite hautement deformable pour dispositifs medicaux |
WO2014011636A1 (fr) | 2012-07-10 | 2014-01-16 | Bio Med Sciences, Inc. | Nouvelle contre-mesure médicale destinée à des premiers intervenants, en cas de brûlures thermiques et/ou radiologiques affectant un très grand nombre de blûlés |
EP2872074A4 (fr) * | 2012-07-10 | 2016-04-20 | Bio Medical Sciences Inc | Nouvelle contre-mesure médicale destinée à des premiers intervenants, en cas de brûlures thermiques et/ou radiologiques affectant un très grand nombre de blûlés |
WO2021032361A1 (fr) * | 2019-08-19 | 2021-02-25 | Sigvaris Ag | Vêtement de compression médical doté d'une section d'articulation spéciale pour une plage de mouvement accrue |
US20220265480A1 (en) * | 2019-08-19 | 2022-08-25 | Sigvaris Ag | Medical compression garment with a special joint section for increased range of motion |
Also Published As
Publication number | Publication date |
---|---|
GB0712714D0 (en) | 2007-08-08 |
WO2009004282A3 (fr) | 2009-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2012314476B2 (en) | Improved wound dressing | |
JP4782253B2 (ja) | 過形成性瘢痕包帯 | |
US4561435A (en) | Wound dressing | |
US5025783A (en) | Method of applying a medical dressing device | |
US4730611A (en) | Medical dressing device | |
JPH1156900A (ja) | 創傷用吸収包帯 | |
Thomas | Atraumatic dressings | |
WO2004014444A1 (fr) | Pansements absorbants jetables avec additifs de traitement pour la sante dermatologique | |
EP1333788A1 (fr) | Pansements avec couche d'hydrogels | |
WO2013028966A2 (fr) | Pansement pour plaie contenant du charbon actif | |
JP2017532178A (ja) | 創傷被覆用具 | |
Joshi et al. | Composite dressings for wound care | |
CN103917206A (zh) | 吸收泡沫带及其制备方法 | |
Qin | Advanced wound dressings | |
WO2009004282A2 (fr) | Pansement médical | |
US20170209311A1 (en) | Absorbent articles with non-adherent member | |
US10292869B2 (en) | Article for absorbing a physiological liquid, such as a dressing | |
KR200359390Y1 (ko) | 의료용 패치 | |
US20240016974A1 (en) | Transparent dressing with hydrogel layer | |
EP1653899B1 (fr) | Feuille absorbante anti-fuites pour pansement | |
Auböck | Synthetic dressings | |
CZ36840U1 (cs) | Krycí prostředek | |
WO2024064336A1 (fr) | Pansement transparent avec couche d'hydrogel | |
Flett et al. | Modern wound management: review of common products | |
ES2575784T3 (es) | Apósito para heridas mejorado |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08762343 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08762343 Country of ref document: EP Kind code of ref document: A2 |